Back to today’s briefing

Story perspectives

UC Davis Breakthrough: FIP Treatment Could Benefit Humans

7/16/2025

42 9

Summary

Story summary

Researchers at UC Davis are making groundbreaking strides in understanding feline infectious peritonitis (FIP), a disease that mirrors long COVID in humans. Their clinical trial revealed that mesenchymal stromal cell therapy significantly boosts immune function in affected cats. This promising research could pave the way for new treatments, bridging the gap between pet and human health challenges.

1 of 1

Story summary

Researchers at UC Davis are making groundbreaking strides in understanding feline infectious peritonitis (FIP), a disease that mirrors long COVID in humans. Their clinical trial revealed that mesenchymal stromal cell therapy significantly boosts immune function in affected cats. This promising research could pave the way for new treatments, bridging the gap between pet and human health challenges.